| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 31-Aug-08 | | Total Revenue | 12,238 | 1,109 | 1,233 | 5,699 | | Cost of Revenue | (1,553) | 462 | 1,091 | 1,328 | | | Gross Profit | 13,791 | 647 | 142 | 4,371 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,748 | 826 | 295 | 579 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 9,972 |
-
|
-
| (9,019) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,071 | (179) | (153) | 12,811 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,950 | 8,582 | (4,984) | (21,229) | | Earnings Before Interest And Taxes | 1,071 | (179) | (153) | (1,620) | | Interest Expense | 341 | 296 | 384 | 1,003 | | Income Before Tax | 730 | (475) | (537) | (2,623) | | Income Tax Expense | 290 | (204) | (192) | (386) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,390 | 8,311 | (5,329) | (9,035) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,390 | 8,311 | (5,329) | (9,035) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,390 | $8,311 | ($5,329) | ($9,035) |
|
0.41% Nasdaq 
Income Statement
